Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-10-31 Sale | 2022-11-02 4:54 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 2,100 | $24.05 | $50,495 | 45,283 (Direct) | View |
| 2022-10-25 Sale | 2022-10-27 6:48 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 9,348 | $20.77 | $194,191 | 47,383 (Direct) | View |
| 2022-10-20 Sale | 2022-10-24 5:13 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 6,080 | $18.66 | $113,426 | 56,731 (Direct) | View |
| 2022-09-26 Sale | 2022-09-28 5:08 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 1,544 | $15.45 | $23,854 | 62,811 (Direct) | View |
| 2022-09-21 Sale | 2022-09-23 4:55 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 4,293 | $15.11 | $64,878 | 64,355 (Direct) | View |
| 2022-09-15 Sale | 2022-09-19 4:34 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 100 | $15.01 | $1,501 | 68,648 (Direct) | View |
| 2022-09-08 Sale | 2022-09-12 4:14 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 1,777 | $15.11 | $26,845 | 68,748 (Direct) | View |
| 2022-06-27 Sale | 2022-06-29 4:02 pm | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 7,714 | $13 | $100,282 | 64,893 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-03-01 Option Award | 2023-03-03 4:33 pm | N/A 2033-03-01 | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 71,400 | $0 | 115,655 (Direct) | View |
| 2023-03-02 Tax Withholding | 2023-03-03 4:33 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 1,028 | $11.6 | 115,655 (Direct) | View |
| 2022-09-01 Option Award | 2022-09-06 4:32 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 5,632 | $0 | 70,525 (Direct) | View |
| 2022-07-01 Option Award | 2022-07-06 4:18 pm | N/A 2032-07-01 | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 33,788 | $0 | 33,788 (Direct) | View |
| 2022-03-01 Option Award | 2022-03-03 4:11 pm | N/A 2032-03-01 | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 78,838 | $0 | 140,182 (Direct) | View |
| 2021-10-28 Option Award | 2021-11-01 6:58 pm | N/A 2031-10-28 | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 95,148 | $0 | 95,148 (Direct) | View |
Ownership | 2021-10-28 8:58 pm | N/A N/A | Entrada Therapeutics Inc. | TRDA | Dowden Nathan J Chief Operating Officer | 0 | $0 | 279,411 (Direct) | View |